eFFECTOR Therapeutics (EFTR) Short Interest Ratio & Short Volume → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free EFTR Stock Alerts $1.78 -0.11 (-5.82%) (As of 04/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media eFFECTOR Therapeutics Short Interest DataCurrent Short Volume345,200 sharesPrevious Short Volume318,100 sharesChange Vs. Previous Month+8.52%Dollar Volume Sold Short$4.97 millionShort Interest Ratio / Days to Cover1.0Last Record DateMarch 31, 2024Outstanding Shares3,687,000 sharesFloat Size3,220,000 sharesShort Percent of Float10.72%Today's Trading Volume146,037 sharesAverage Trading Volume337,769 sharesToday's Volume Vs. Average43% Short Selling eFFECTOR Therapeutics ? Sign up to receive the latest short interest report for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEFTR Short Interest Over TimeEFTR Days to Cover Over TimeEFTR Percentage of Float Shorted Over Time Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! eFFECTOR Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024345,200 shares $4.97 million +8.5%10.7%1 $14.39 3/15/2024318,100 shares $3.52 million +43.1%15.0%2.2 $11.06 2/29/2024222,300 shares $3.21 million +113.8%10.5%1.6 $14.44 2/15/2024104,000 shares $1.21 million -4.4%4.9%0.9 $11.66 1/31/2024108,800 shares $1.25 million -12.6%5.9%1 $11.47 1/15/2024124,500 shares $1.33 million -85.0%6.7%1.3 $10.69 Get the Latest News and Ratings for EFTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023827,900 shares $386,960.46 -21.9%1.8%0.4 $0.47 12/15/20231,060,000 shares $398,348.00 +1.0%2.3%0.6 $0.38 11/30/20231,050,000 shares $556,920.00 +141.9%2.3%0.8 $0.53 11/15/2023434,000 shares $253,890.00 +72.8%1.0%0.6 $0.59 10/31/2023251,100 shares $135,594.00 -50.5%0.7%0.6 $0.54 10/15/2023507,600 shares $291,057.84 +133.9%1.3%1.1 $0.57 9/30/2023217,000 shares $130,178.30 -74.0%0.6%0.5 $0.60 9/15/2023834,100 shares $508,801.00 -8.5%2.2%1.4 $0.61 8/31/2023912,000 shares $663,936.00 +36.7%2.4%1 $0.73 8/15/2023667,400 shares $453,231.34 -38.8%1.7%0.3 $0.68 7/31/20231,090,000 shares $881,156.00 -15.5%3.6%0.5 $0.81 7/15/20231,290,000 shares $990,720.00 +219.3%4.2%0.6 $0.77 6/30/2023404,000 shares $335,400.80 +91.4%1.4%0.2 $0.83 6/15/2023211,100 shares $197,378.50 -83.0%0.8%0.1 $0.94 5/31/20231,240,000 shares $1.15 million +1,506.2%4.6%0.8 $0.93 5/15/202377,200 shares $52,874.28 -12.6%0.4%0.4 $0.68 4/30/202388,300 shares $41,501.00 -32.5%0.6%0.5 $0.47 4/15/2023130,800 shares $50,358.00 +236.3%0.7%0.7 $0.39 3/31/202338,900 shares $13,720.03 -45.2%0.1%0.2 $0.35 3/15/202371,000 shares $28,400.00 +110.7%0.2%0.2 $0.40 2/28/202333,700 shares $16,789.34 -72.2%0.3%0.1 $0.50 2/15/2023121,300 shares $72,780.00 -9.1%0.9%0.4 $0.60 1/31/2023133,400 shares $68,447.54 -29.3%1.0%0.4 $0.51 1/15/2023188,800 shares $84,960.00 +56.4%1.4%0.7 $0.45 12/30/2022120,700 shares $51,611.32 +148.9%0.9%0.5 $0.43 12/15/202248,500 shares $19,400.00 +41.4%0.4%0.5 $0.40 11/30/202234,300 shares $14,399.14 -49.9%0.3%0.3 $0.42 11/15/202268,400 shares $37,695.24 -51.7%0.5%0.5 $0.55 10/31/2022141,600 shares $86,758.32 +13.2%1.1%0.1 $0.61 10/15/2022125,100 shares $73,296.09 -42.5%1.0%0.1 $0.59 9/30/2022217,500 shares $124,431.75 +55.0%1.7%0.2 $0.57 9/15/2022140,300 shares $83,071.63 -25.5%1.1%0.1 $0.59 8/31/2022188,300 shares $114,768.85 +21.5%1.4%0.2 $0.61 8/15/2022155,000 shares $111,026.50 +104.8%1.3%0.1 $0.72Now Open: Crypto emergency update (Ad)During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. EFTR Short Interest - Frequently Asked Questions What is eFFECTOR Therapeutics' current short interest? Short interest is the volume of eFFECTOR Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 345,200 shares of EFTR short. 10.72% of eFFECTOR Therapeutics' shares are currently sold short. Learn More on eFFECTOR Therapeutics' current short interest. What is a good short interest ratio for eFFECTOR Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EFTR shares currently have a short interest ratio of 1.0. Learn More on eFFECTOR Therapeutics's short interest ratio. What is a good short interest percentage for eFFECTOR Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.72% of eFFECTOR Therapeutics' floating shares are currently sold short. Is eFFECTOR Therapeutics' short interest increasing or decreasing? eFFECTOR Therapeutics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 345,200 shares, an increase of 8.5% from the previous total of 318,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is eFFECTOR Therapeutics' float size? eFFECTOR Therapeutics currently has issued a total of 3,687,000 shares. Some of eFFECTOR Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. eFFECTOR Therapeutics currently has a public float of 3,220,000 shares. How does eFFECTOR Therapeutics' short interest compare to its competitors? 10.72% of eFFECTOR Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to eFFECTOR Therapeutics: Chemomab Therapeutics Ltd. (1.87%), Trevena, Inc. (0.63%), Pasithea Therapeutics Corp. (1.17%), Tenax Therapeutics, Inc. (2.62%), Pulmatrix, Inc. (0.07%), Lixte Biotechnology Holdings, Inc. (0.97%), Sunshine Biopharma, Inc. (0.77%), Clever Leaves Holdings Inc. (1.15%), ASLAN Pharmaceuticals Limited (0.73%), Enveric Biosciences, Inc. (4.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short eFFECTOR Therapeutics stock? Short selling EFTR is an investing strategy that aims to generate trading profit from eFFECTOR Therapeutics as its price is falling. EFTR shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against eFFECTOR Therapeutics? A short squeeze for eFFECTOR Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EFTR, which in turn drives the price of the stock up even further. How often is eFFECTOR Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EFTR, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: CMMB Short Interest Data TRVN Short Interest Data KTTA Short Interest Data TENX Short Interest Data PULM Short Interest Data LIXT Short Interest Data SBFM Short Interest Data CLVR Short Interest Data ASLN Short Interest Data ENVB Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EFTR) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceUrgent alert: open this for a huge profit potentialTimothy SykesHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle Publishing